Analysis of miRNA Expression in Patients with Rheumatoid Arthritis during Olokizumab Treatment

Analysis of miRNA Expression in Patients with Rheumatoid Arthritis during Olokizumab Treatment

Rheumatoid arthritis (RA) is the most common autoimmune disease worldwide. Epigenetic alternations of microRNAs (miRNAs) can contribute to its pathogenesis and progression. As the first line therapy with DMARDs is not always successful, other drugs and therapeutic targets should be applied. This stu...

Full description

Bibliographic Details
Main Authors: Irina V. Bure, Dmitry S. Mikhaylenko, Ekaterina B. Kuznetsova, Ekaterina A. Alekseeva, Kristina I. Bondareva, Alexey I. Kalinkin, Alexander N. Lukashev, Vadim V. Tarasov, Andrey A. Zamyatnin, Marina V. Nemtsova
Format: Article
Language:English
Published: MDPI AG 2020-10-01
Series:Journal of Personalized Medicine
Subjects:
rheumatoid arthritis
microRNA
biomarker
personalized medicine
Online Access:https://www.mdpi.com/2075-4426/10/4/205

Internet

https://www.mdpi.com/2075-4426/10/4/205

Similar Items